SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-197707
Filing Date
2023-07-28
Accepted
2023-07-28 16:10:46
Documents
12
Period of Report
2023-07-27
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K d466655d8k.htm   iXBRL 8-K 37626
  Complete submission text file 0001193125-23-197707.txt   157975

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA hznp-20230727.xsd EX-101.SCH 2869
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE hznp-20230727_lab.xml EX-101.LAB 17168
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE hznp-20230727_pre.xml EX-101.PRE 10801
6 EXTRACTED XBRL INSTANCE DOCUMENT d466655d8k_htm.xml XML 3355
Mailing Address CONNAUGHT HOUSE, 1ST FLOOR 1 BURLINGTON ROAD DUBLIN L2 4
Business Address CONNAUGHT HOUSE, 1ST FLOOR 1 BURLINGTON ROAD DUBLIN L2 4 011-353-1-772-2100
Horizon Therapeutics Public Ltd Co (Filer) CIK: 0001492426 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35238 | Film No.: 231123135
SIC: 2834 Pharmaceutical Preparations